Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Patients Are Not Associated with Increased Lymphoma Risk

被引：0
|
作者：
Wong, A. K.
Kerkoutian, S.
Said, J. W.
Rashidi, H.
Pullarkat, S. T.
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] UCSD, San Diego, CA USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1470
引用
收藏
页码：329A / 329A
页数：1
相关论文
共 50 条
  • [1] Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Patients Are Not Associated with Increased Lymphoma Risk
    Wong, A. K.
    Kerkoutian, S.
    Said, J. W.
    Rashidi, H.
    Pullarkat, S. T.
    [J]. LABORATORY INVESTIGATION, 2010, 90 : 329A - 329A
  • [2] Anti-tumor necrosis factor α therapy and the risk of lymphoma in rheumatoid arthritis:: No clear answer
    Symmons, DPM
    Silman, AJ
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (06): : 1703 - 1706
  • [3] Breast Lymphoma Complicating Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis
    Pattanaik, Debendra
    Koduru, Swapna
    Azouz, Abdallah
    Patil, Sadanand
    Carbone, Laura
    [J]. CLINICAL BREAST CANCER, 2011, 11 (06) : 413 - 416
  • [4] Anti-tumor necrosis factor therapy was not associated with greater risk for mortality than standard therapy in rheumatoid arthritis
    Schattner, Ami
    [J]. ANNALS OF INTERNAL MEDICINE, 2011, 154 (06) : JC3 - 13
  • [5] Use of Anti-Tumor Necrosis Factor Therapy Is Associated with Reduced Cardiovascular Event Risk in Rheumatoid Arthritis
    Nurmohamed, Mike
    Bao, Yanjun
    Signorovitch, James
    Mulani, Parvez M.
    Furst, Daniel E.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S531 - S531
  • [6] Rheumatoid Arthritis Risk Allele PTPRC Is Also Associated With Response to Anti-Tumor Necrosis Factor α Therapy
    Cui, Jing
    Saevarsdottir, Saedis
    Thomson, Brian
    Padyukov, Leonid
    van der Helm-van Mil, Annette H. M.
    Nititham, Joanne
    Hughes, Laura B.
    de Vries, Niek
    Raychaudhuri, Soumya
    Alfredsson, Lars
    Askling, Johan
    Wedren, Sara
    Ding, Bo
    Guiducci, Candace
    Wolbink, Gert Jan
    Crusius, J. Bart A.
    van der Horst-Bruinsma, Irene E.
    Herenius, Marieke
    Weinblatt, Michael E.
    Shadick, Nancy A.
    Worthington, Jane
    Batliwalla, Franak
    Kern, Marlena
    Morgan, Ann W.
    Wilson, Anthony G.
    Isaacs, John D.
    Hyrich, Kimme
    Seldin, Michael F.
    Moreland, Larry W.
    Behrens, Timothy W.
    Allaart, Cornelia F.
    Criswell, Lindsey A.
    Huizinga, Tom W. J.
    Tak, Paul P.
    Bridges, S. Louis, Jr.
    Toes, Rene E. M.
    Barton, Anne
    Klareskog, Lars
    Gregersen, Peter K.
    Karlson, Elizabeth W.
    Plenge, Robert M.
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (07): : 1849 - 1861
  • [7] Anti-tumor necrosis factor a therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis
    Schneeweiss, Sebastian
    Setoguchi, Soko
    Weinblatt, Michael E.
    Katz, Jeffrey N.
    Avorn, Jerry
    Sax, Paul E.
    Levin, Raisa
    Solomon, Daniel H.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 1754 - 1764
  • [8] Adherence to Anti-Tumor Necrosis Factor Therapy Administered Subcutaneously and Associated Factors in Patients With Rheumatoid Arthritis
    Salaffi, Fausto
    Carotti, Marina
    Di Carlo, Marco
    Farah, Sonia
    Gutierrez, Marwin
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2015, 21 (08) : 419 - 425
  • [9] Anti-tumor necrosis factor therapy with infliximab decreases the risk of stroke in patients with rheumatoid arthritis.
    Wolfe, F
    Nadareishvili, ZG
    Hallenbeck, JM
    Michaud, K
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4099 - 4099
  • [10] Lymphoma in rheumatoid arthritis - The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients
    Wolfe, F
    Michaud, K
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (06): : 1740 - 1751
12345